Stabbing takes place in Mass. General Hospital lobby in Boston
The Boston Police Department is investigating a stabbing that took place in the lobby of Massachusetts General Hospital.
At about 8:32 a.m. on Thursday, officers responded to a report of a stabbing inside of Massachusetts General Hospital, according to a department spokesperson.
The spokesperson said the stabbing took place in the vestibule of the lobby.
When officers arrived, they found an adult who was suffering from a non-life-threatening stab wound. A suspect was identified and was taken into custody within the area of 90 Blossom St., the spokesperson said.
No names were given for the victim or suspect.
The victim was stabbed in one of the hospital's lobbies and was treated for minor injuries and was released, according to Massachusetts General Hospital.
'The hospital is safe, open, and operating normally,' an email from the hospital reads. 'We are grateful to our staff and Boston Police for their quick response in bringing this incident to a close.'
The stabbing comes two days after a 46-year-old man stole a Boston Police officer's gun outside of Massachusetts General Hospital — firing it during a fight and injuring himself.
Elvis Haughton was charged with assault and battery on a police officer, illegal possession of a firearm, possession of a class C substance and resisting arrest.
During his appearance in court on Wednesday, a judge ordered Haughton to undergo a mental health evaluation. He was ordered held without bail until his dangerousness hearing on June 2.
Boston Police ID suspect in connection with hospital lobby stabbing
Giggity, giggity: 'Family Guy'-themed pop-up coming to Boston this summer
New outdoor restaurant brings modern Asian creations, cocktails to Somerville
Boston woman sentenced for identity theft in drug trafficking scheme
Boston shooting suspect didn't get a court-appointed attorney — and you might not either
Read the original article on MassLive.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Boston Globe
18 minutes ago
- Boston Globe
Search for answers: Mystery haunts family of missing mom from Brighton 50 years after she vanished
Goroshko, who lived on Monastery Road in Brighton, 'It's 50 years yesterday that she disappeared,' her son, Rick, said in a phone interview Thursday. 'Her life was cut short. She never got to live her life and be with her family ... she never got to see her grandkids or great-grandkids.' Three years ago the Boston Police Department appealed to the public for help and Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'Any piece of information, no matter how small or seemingly insignificant, could make a tremendous difference in the course of this decades long investigation,' Boston police said at the time. Advertisement Today Goroshko's loved ones are still waiting for answers, and her family is offering a $50,000 reward for any information that leads to the discovery of her remains. 'I want to give her a proper burial,' Rick said. Rick was 14 years old when his mother went missing. His older brother was 20 and his younger brother was 12. 'It was a time full of loss and confusion,' he said. 'Wondering where she is. Is she coming home? Not knowing what happened. It's just a hole in your heart that never heals.' Advertisement Adventures With Purpose, a group of divers who use underwater sonar imaging to locate vehicles in bodies of water, recently searched Jamaica Pond and the Charles River for Goroshko's gold 1970 Ford Maverick, but to no avail. 'They found a lot of vehicles, but unfortunately they did not find my mother's vehicle,' he said. Hans Hug, who owns Sonar Search & Recovery, a business in Exeter, N.H. that specializes in underwater search and recovery operations , has also located five vehicles in the Charles River that could potentially be Goroshko's. Hug plans to dive to the vehicles and hopefully identify them. Rick, 64, who lives in Pennsylvania, holds out hope that her mother's car could contain evidence that could 'hold somebody accountable.' 'We're kind of running out of time to get someone to come forward who knows something,' he said. 'Somebody knows something. Maybe it's time they cleared their conscience, and make things right.' The Boston Police Department Unsolved Homicide Unit is asking anyone with information that could be helpful to the investigation to contact 617-343-4470 or leave an anonymous tip by calling the CrimeStoppers Tip Line at 1-800-494-TIPS or by texting the word 'TIP' to CRIME (27463). Dorothy P. Goroshko hasn't been seen since June 4, 1975. Boston Police Department #mc_embed_signup{background:#fff; false;clear:left; font:14px Helvetica,Arial,sans-serif; width: 100%;} /* Add your own Mailchimp form style overrides in your site stylesheet or in this style block. We recommend moving this block and the preceding CSS link to the HEAD of your HTML file. */ Sign up for Cold Case Files emails: * indicates required Email Address * First Name Emily Sweeney can be reached at
Yahoo
an hour ago
- Yahoo
Pfizer (NYSE:PFE) Exceeds Sales Milestone With Cresemba In Asia Pacific And China
Pfizer announced robust sales for the antifungal drug Cresemba in partnership with Basilea Pharmaceutica Ltd, marking significant growth in key Asian markets. Despite this achievement, Pfizer's stock price was relatively flat last week, reflecting a broader market trend rather than significant movements unique to the company. The company's announcements, including significant clinical trial results and strategic drug market expansions, provided positive context. However, these events primarily added weight to the overall market's modest rise, suggesting a stable, yet unremarkable impact on Pfizer's share price amid ongoing economic and trade developments. Be aware that Pfizer is showing 3 risks in our investment analysis. The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 26 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement. Pfizer's recent announcement concerning Cresemba's sales growth in Asian markets is a positive indicator for its revenue outlook. However, despite these gains, Pfizer's shares have remained flat, reflecting broader market trends rather than company-specific news. This lack of movement underscores persistent challenges, such as competition and declining utilization of key drugs like Paxlovid and Vyndaqel, potentially impacting future revenues and earnings forecasts. Over the past five years, Pfizer's total shareholder return, including dividends, was a decrease of 13.55%. This decline highlights performance concerns, particularly as Pfizer underperformed the broader US market, which recorded an 11.6% gain over the last year. Despite becoming profitable this year, Pfizer's forecasted revenue contraction of 2.1% per year over the next three years reflects ongoing challenges within the pharmaceutical industry. Pfizer's current share price at approximately US$24.41 shows a sizable discount compared to the consensus analyst price target of US$29.24. This gap suggests moderate investor skepticism about future growth, as analysts expect profit margins to rise yet predict revenue and earnings pressures. While Pfizer aims to stabilize through R&D advancements and international market penetration, these efforts will need to counteract competition's influence to align closer with the anticipated price target. Unlock comprehensive insights into our analysis of Pfizer stock in this financial health report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NYSE:PFE. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
Report accuses NHS health trust of 'nepotism'
A report has uncovered allegations of nepotism and inequality at an NHS mental health trust. The study - led by former NHS equality director Yvonne Coghill - was based on the experiences of 100 members of staff at the Norfolk and Suffolk NHS Foundation Trust (NSFT) and was commissioned by NSFT itself. Findings included evidence that the disciplinary processes for staff from a black, Asian and minority ethnic background (BAME) were "more draconian". Dr Faisil Sethi, NSFT's deputy chief executive, said: "While we have made some progress, we have much more to do to reduce disparity of experience and improve the lives of our colleagues from black and minority ethnic backgrounds." The workforce race equality report found staff felt there were significant discrepancies in recruitment, career progression, the disciplinary process and equal opportunities. It included allegations of "widespread and problematic nepotism" and a fear of speaking up or making complaints. Some staff felt there was no clear process for dealing with racist patients. In the report, NSFT's leadership was accused of not understanding race, and senior leaders were accused of not listening. In the report, Caroline Donovan, NSFT chief executive, said it was her aim to ensure everyone "regardless of background has the best possible experience of working here". She added: "NSFT, similar to many organisations, has challenges of racial disparity which need urgent and sustaining leadership." The report recommended NSFT held a conference about the findings, and conducted an audit of its application process. It said all board members must have a clear and deep understanding of the issues and leaders must listen to BAME staff and commit to being anti-racist. Dr Sethi added that race discrimination was taken "extremely seriously" at NSFT. He said the report was part of the trust's commitment to embrace "cultural diversity and racial equality". Follow Norfolk news on BBC Sounds, Facebook, Instagram and X. Mental health a 'high priority' says government 'Worst' mental health trust shows improvement Norfolk and Suffolk NHS Foundation Trust
